Lupin FY2026 and Q4 FY2026 Results

Pat Growth 25pctEbitda Margin ExpansionRevenue Growth 20pctExceptional ItemResults View source PDF

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-8.9%1-day move

₹2462.00

prior close

₹2425.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.6+2.0+1.6-0.3-8.9-8.6-9.8-8.5-7.2-6.9-8.4-8.7-0.2—

Up moveDown movePending

AI summary

Lupin reported strong FY2026 results with full-year sales of ₹2,74,875 Mn, up 23.9% YoY, driven by robust growth in the U.S. market (up 46% to ₹116,783 Mn). EBITDA grew 68.6% to ₹92,405 Mn with margins expanding 890 bps to 33.6%, while PAT increased 62% to ₹53,555 Mn. Q4 FY2026 showed even stronger momentum with sales up 32.9% and PAT up 87.7% YoY. The company received 3 ANDA approvals taking cumulative approvals to 344. Board recommended dividend of 900%. Balance sheet remains strong with net cash position (Net Debt: -₹46,358 Mn) and Net Debt/Equity of -0.21. R&D investment was ₹20,631 Mn (7.5% of sales).

Likely market impact

Exceptional profit growth and margin expansion signal strong operational performance. The U.S. market turnaround is particularly notable with 46% growth. The net cash balance sheet and 900% dividend indicate confidence in sustained profitability.